A Versatile High‐Throughput Single‐Cell Screening Platform for Profiling Antigen‐Specific Long‐Lived B Cells in Blood and Bone Marrow
Advanced Science · 2025
DOI: 10.1002/advs.202414945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Tian Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Tsinghua University, Beijing, 100084, China. Hauptthemen laut MEDLINE: Single-Cell Analysis, SARS-CoV-2, COVID-19, High-Throughput Screening Assays. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Plan for Scientific Research and Development of China.
Abstract (Originalsprache)
Antigen‐specific B cells play a crucial role in the long‐term immune response following infection or vaccination, differentiating into antibody‐secreting cells (ASCs) and memory B cells (MBCs). However, profiling ASCs is challenging primarily due to their lack of membrane‐bound surface B cell receptors. In this study, the Modular Superhydrophobic Microwell Array Chip (MoSMAR‐chip) is introduced as a versatile, cost‐effective, and high‐throughput platform for identifying and characterizing individual antigen‐specific ASCs and MBCs at the single‐cell level within seven days. Using this platform, comprehensive analyses of single ASCs could be performed from bone marrows of coronavirus disease 2019 (COVID‐19) vaccine‐immunized mice and a diverse set of antibodies capable of neutralizing the highly divergent JN1 variant of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) were identified. These results demonstrate that the MoSMAR‐chip facilitates efficient single‐cell multi‐omics and functional analyses of antigen‐specific ASCs, offering a powerful tool for investigating complex long‐term B cell immunity in diverse clinical conditions, such as infectious diseases, autoimmunity, and beyond.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Tsinghua University, Beijing, 100084, China.
- Comprehensive AIDS Research Center, Center for Global Health and Infectious Diseases Research, NexVac Research Center, Center for Infectious Diseases Research, School of Basic Medical Sciences, Tsinghua Medicine, Tsingh…
- Tsinghua-Peking Joint Center for Life Sciences, Beijing, 100084, China.
- Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, China.
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
- Changping Laboratory, Beijing, 102206, China.
ORCID-Profile: Peng Liu
Förderung
- National Natural Science Foundation of China
- National Key Plan for Scientific Research and Development of China
Zitieren
APA
Zhao, T., Lei, Y., Liu, C., Zhang, D., Li, K., Shan, S., Li, C., Wei, Z., Yang, Y., Zhang, T., Sun, K., Sun, H., Zhang, L., & Liu, P. (2025). A Versatile High‐Throughput Single‐Cell Screening Platform for Profiling Antigen‐Specific Long‐Lived B Cells in Blood and Bone Marrow. Advanced Science. https://doi.org/10.1002/advs.202414945
Vancouver
Zhao T, Lei Y, Liu C, Zhang D, Li K, Shan S, et al. A Versatile High‐Throughput Single‐Cell Screening Platform for Profiling Antigen‐Specific Long‐Lived B Cells in Blood and Bone Marrow. Advanced Science. 2025. doi:10.1002/advs.202414945
BibTeX
@article{Zhao2025,
author = {Zhao, Tian and Lei, Yuqing and Liu, Chang and Zhang, Dong and Li, Kaiyi and Shan, Sisi and Li, Chenyu and Wei, Zimeng and Yang, Yuhan and Zhang, Ting and Sun, Kai and Sun, Haoran and Zhang, Linqi and Liu, Peng},
title = {A Versatile High‐Throughput Single‐Cell Screening Platform for Profiling Antigen‐Specific Long‐Lived B Cells in Blood and Bone Marrow},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202414945}
}
EUVIMED